Q9UNP9 (PPIE_HUMAN) Homo sapiens (Human)
Peptidyl-prolyl cis-trans isomerase E UniProtKBInterProSTRINGInteractive Modelling
301 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3);
4 identical sequences: Pan troglodytes: A0A2I3TM89, A0A6D2XNL7; Pan paniscus: A0A2R9CMW0; Gorilla gorilla gorilla: A0A2I2YPM6
Available Structures
27 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Human pre-Bact-2 spliceosome |
Heteromer O43660; O60306; O60508; O60870; O75533; O75643; P08579; P09661; P14678; P41223; P55081; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8IYB3; Q8NAV1; Q8TAD8; Q8WYA6; Q96DI7; Q96NC0; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9BZL1; Q9HCS7; Q9NW64; Q9P013; Q9Y388; Q9Y3B4; | 1×GTP; 1×MG; 1×IHP; | ||||
Assess | ||||||
human Bact spliceosome core structure |
Heteromer O15541; O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q13573; Q15029; Q15393; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8IYB3; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9ULR0; Q9UMS4; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6; | 11×ZN; 5×MG; 1×IHP; 1×GTP; 2×ADP; | ||||
Assess | ||||||
The Cryo-EM Structure of Human Catalytic Step I Spliceosome (C complex) at 4.1 angstrom resolution |
Heteromer O15234; O43660; O60306; O60508; O75643; O75934; O95926; P08579; P09661; P14678; P38919; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13427; Q13573; Q15029; Q6P2Q9; Q92620; Q96A72; Q96BP3; Q96DI7; Q99459; Q9BW85; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9NXE8; Q9P013; Q9ULR0; Q9UMS4; Q9UQ35; Q9Y3C6; Q9Y5S9; | 1×IHP; 1×GTP; 7×MG; 2×ADP; 7×ZN; 1×ATP; | ||||
Assess | ||||||
Cryo-EM structure of a human spliceosome activated for step 2 of splicing (C* complex) |
Heteromer O43660; O60306; O60508; O75934; O95926; P08579; P09661; P14678; P38919; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14562; Q15029; Q6P2Q9; Q96DI7; Q99459; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UQ35; Q9Y3C6; | |||||
Assess | ||||||
Structure of a late-stage activated spliceosome (BAqr) arrested with a dominant-negative Aquarius m… |
Heteromer O15541; O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8WUA2; Q92917; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9ULR0; Q9UMS4; Q9UQ35; Q9Y3C6; | 12×ZN; 1×IHP; 1×GTP; 7×MG; | ||||
Assess | ||||||
cryo-EM structure of a human activated spliceosome (mature Bact) at 5.1 angstrom. |
Heteromer O15541; O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6; | 1×IHP; 1×GTP; 6×MG; 13×ZN; | ||||
Assess | ||||||
Cryo-EM structure of the human activated spliceosome (late Bact) at 6.5 angstrom |
Heteromer O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6; | 1×IHP; 1×ALA; 1×GTP; 6×MG; 10×ZN; | ||||
Assess | ||||||
Complex Cyp33-RRM : MLL1-PHD3 |
Heteromer Q03164; | 2×ZN; | ||||
Assess | ||||||
Trimolecular complex Cyp33-RRMdelta alpha : MLL1-PHD3 : H3K4me3 |
Heteromer Q03164; Q6NXT2; | 2×ZN; | ||||
Assess | ||||||
The cryo-EM structure of human pre-C*-II complex |
Heteromer O15234; O43660; O60306; O60508; O75934; O95391; O95926; P08579; P09661; P14678; P38919; P41223; P61326; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14562; Q15029; Q6P2Q9; Q8WUQ7; Q96DI7; Q99459; Q9BZJ0; Q9GZU8; Q9H875; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UQ35; Q9Y3C6; Q9Y421; Q9Y5S9; | 1×IHP; 1×GTP; 9×MG; 7×ZN; 1×ATP; | ||||
Assess | ||||||
The cryo-EM structure of human C* complex |
Heteromer O15234; O43660; O60306; O60508; O75643; O75934; O95391; O95926; P08579; P09661; P14678; P38919; P41223; P61326; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14562; Q15029; Q6P2Q9; Q8N5F7; Q8WUQ7; Q96DI7; Q99459; Q9BZJ0; Q9H875; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UQ35; Q9Y3C6; Q9Y421; Q9Y5S9; | 1×IHP; 1×GTP; 9×MG; 7×ZN; 1×ATP; | ||||
Assess | ||||||
Cryo-EM structure of a human intron lariat spliceosome after Prp43 loaded (ILS2 complex) at 2.9 ang… |
Heteromer O43143; O43660; O60306; O60508; O75934; O95926; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q15029; Q2TBE0; Q6P2Q9; Q96DI7; Q99459; Q9BZJ0; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9Y3C6; | 1×IHP; 1×GTP; 7×MG; 7×ZN; | ||||
Assess | ||||||
Cryo-EM structure of a human intron lariat spliceosome prior to Prp43 loaded (ILS1 complex) at 2.9 … |
Heteromer O43660; O60306; O60508; O75934; O95926; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q15029; Q2TBE0; Q6P2Q9; Q96DI7; Q99459; Q9BZJ0; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9Y3C6; | 1×IHP; 1×GTP; 7×MG; 7×ZN; | ||||
Assess | ||||||
Cryo-EM structure of a human post-catalytic spliceosome (P complex) at 3.0 angstrom |
Heteromer O15234; O43660; O60306; O60508; O75643; O75934; O95391; O95926; P08579; P09661; P14678; P38919; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14562; Q15029; Q6P2Q9; Q96A72; Q96DI7; Q99459; Q9BZJ0; Q9H875; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UQ35; Q9Y3C6; Q9Y5S9; | 1×IHP; 1×GTP; 9×MG; 7×ZN; 1×ATP; | ||||
Assess | ||||||
The cryo-EM structure of human pre-C*-I complex |
Heteromer O15234; O43660; O60306; O60508; O75934; O95926; P08579; P09661; P14678; P38919; P41223; P61326; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14562; Q15029; Q6P2Q9; Q96DI7; Q99459; Q9BZJ0; Q9GZU8; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UQ35; Q9Y3C6; Q9Y5S9; | 1×IHP; 1×GTP; 9×MG; 6×ZN; 1×ATP; | ||||
Assess | ||||||
Human C Complex Spliceosome - Medium-resolution PERIPHERY |
Heteromer O60306; O60508; O75643; O75934; O95926; P08579; P09661; P14678; P38919; P61326; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14331; Q6P2Q9; Q92620; Q96BP3; Q99459; Q9BW85; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9NW82; Q9ULR0; Q9UMS4; Q9UQ35; Q9Y5S9; | |||||
Assess | ||||||
Crystal structure of a peptidyl-prolyl cis-trans isomerase E (PPIE) from Homo sapiens at 2.50 A res… | monomer | |||||
Assess | ||||||
Crystal structure of cyclophilin ABH-like domain of human peptidylprolyl isomerase E isoform 1 | monomer | |||||
Assess | ||||||
C domain of human cyclophilin-33(hcyp33) | monomer | |||||
Assess | ||||||
Complex Cyp33-RRM : AAUAAA RNA | monomer | |||||
Assess | ||||||
Free form of extended Cyp33-RRM | monomer | |||||
Assess | ||||||
Complex Cyp33-RRMdelta alpha : UAAUGUCG RNA | monomer | |||||
Assess | ||||||
Solution Structure of the RNA recognition motif in Peptidyl-prolyl cis-trans isomerase E | monomer | |||||
Assess | ||||||
Crystal structure of the RRM domain of Cyclophilin 33 | monomer | |||||
Assess | ||||||
Solution structure of the RRM domain of CYP33 | monomer | |||||
Assess | ||||||
Solution structure of MLL1 PHD3-Cyp33 RRM chimeric protein | monomer | |||||
Assess | ||||||
Crystal structure of the RRM domain of CyP33 | monomer | 2×SO4; | ||||
Assess |
3 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
7abi.1.6 | monomer | 0.69 | 100.00 | |||
Assess | ||||||
6ff7.1.t | monomer | 0.65 | 100.00 | |||
Assess | ||||||
8ch6.1.t | monomer | 0.56 | 100.00 | |||
Assess |
6 SWISS-MODEL models built on isoform sequence
Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
---|---|---|---|---|---|---|
Isoform 2 | 7abi.1.6 | monomer | 0.66 | 98.59 | ||
Assess | ||||||
Isoform 2 | 6ff7.1.t | monomer | 0.63 | 98.59 | ||
Assess | ||||||
Isoform 2 | 8ch6.1.t | monomer | 0.53 | 98.59 | ||
Assess | ||||||
Isoform 3 | 6ff7.1.t | monomer | 0.64 | 98.24 | ||
Assess | ||||||
Isoform 3 | 7abi.1.6 | monomer | 0.63 | 97.59 | ||
Assess | ||||||
Isoform 3 | 8ch6.1.t | monomer | 0.51 | 97.59 | ||
Assess |